Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (2)
- (-) Physics (1)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (2)
- Biology (2)
- Chemical Sciences (1)
- Computer Science (4)
- Coronavirus (2)
- Fusion (1)
- High-Performance Computing (1)
- Materials (3)
- Materials Science (5)
- Microscopy (1)
- Nanotechnology (2)
- Neutron Science (14)
- Quantum Computing (1)
- Quantum Science (2)
- Space Exploration (1)
- Transportation (1)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
The COHERENT particle physics experiment at the Department of Energy’s Oak Ridge National Laboratory has firmly established the existence of a new kind of neutrino interaction.